Results 11 to 20 of about 1,206,776 (294)

Dose intensity in cancer chemotherapy [PDF]

British Journal of Cancer, 1990
The purpose of this review is to assess the evidence that dose and dose intensity are important determinants of outcome in the treatment of human cancer with cytotoxic ...
D J, Dodwell, H, Gurney, N, Thatcher
openaire   +2 more sources

Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study

BMC Cancer, 2022
Background S-1 adjuvant chemotherapy is the standard treatment in Asia for resectable pancreatic ductal adenocarcinoma. The relative dose intensity of adjuvant chemotherapy influences survival in pancreatic cancer but does not precisely reflect treatment
Kazuki Kobayashi, Takahiro Einama, Yasuhiro Takihata, Naoto Yonamine, Ibuki Fujinuma, Takazumi Tsunenari, Keita Kouzu, Akiko Nakazawa, Toshimitsu Iwasaki, Hideki Ueno, Yoji Kishi   +10 more
doaj   +1 more source

The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer

BMC Cancer, 2022
Background An uninterrupted dose of oxaliplatin-based cytotoxic therapy is an essential component in the standard treatment regimen of metastatic colon cancer (mCC). Data on the impacts of dose intensity reduction on the palliative treatment for patients
Mohd Naqib Zainal Abidin, Marhanis Salihah Omar, Farida Islahudin, Noraida Mohamed Shah   +3 more
doaj   +1 more source

Overview of the sensitivity of Ge- and Al-doped silicon dioxide optical fibres to ionizing radiation [PDF]

, 2012
This paper reviews the thermoluminescence sensitivity of Ge- and Al- doped SiO2 optical fibre subjected to various ionizing radiations. It is found that the Ge- doped SiO2 optical fiber has the thermoluminescence response superior to Al-doped SiO2 ...
Hashim, Suhairul, Hussin, Rosli, Lim, Tou Ying, Wagiran, Husin   +3 more
core   +1 more source

Cisplatin-lnduced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity [PDF]

Cancer, 1992
The authors prospectively evaluated the effects of three different schedules of cisplatin (DDP) administration in 60 patients with advanced epithelial ovarian cancer. The individual total dose of DDP was 450 mg/m2 in all three groups, and the anti-cancer response at the end of treatment was similar for the different regimens.
Cavaletti, GA, Marzorati, L, Bogliun, G, Colombo, N, Marzola, M, Pittelli, MR, Tredici, G   +6 more
openaire   +3 more sources

Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database

Cancer Medicine, 2020
Background Sorafenib has been shown to improve survival in patients with advanced hepatocellular carcinoma (HCC), however, full dose can be difficult to tolerate.
Mohammed A. Alghamdi, Carla P. Amaro, Richard Lee‐Ying, Hao‐Wen Sim, Haider Samwi, Kelvin K. Chan, Jennifer J. Knox, Yoo‐Joung Ko, Mina Swiha, Eugene Batuyong, Adriana Romagnino, Winson Y. Cheung, Vincent C. Tam, the Hepatocellular Carcinoma ‐ Cancer Health Outcomes Research Database (HCC ‐ CHORD) Consortium   +13 more
doaj   +1 more source

Speech and language therapy for aphasia following stroke [PDF]

, 2016
Background  Aphasia is an acquired language impairment following brain damage that affects some or all language modalities: expression and understanding of speech, reading, and writing.
Albert, Albert, Altman, Altmann, Ambrosi, Avent, Avent, Bakheit, Basso, Bastiaanse, Baumgaertner, Benjamin, Benson, Berman, Best, Beukelman, Bhogal, Blomert, Bloom, Borkowski, Bowen, Boyle, Bradburn, Brady, Breitenfeld, Brooks, Brott, Caplan, Carlo, Castro-Caldas, Caute, Cherney, Cherney, Cherney, Cherney, Cherney, Cherney, Ciccone, Code, Cohen, Cohen, Conklyn, Crerar, Crosson, Crosson, Cupit, David, David, David, David, David, Denes, DeRenzi, Ding, Doesborgh, Doesborgh, Druks, Drummond, Dubner, Duffy, Dunn, Ebrahim, Elman, Elman, Elsner, Enderby, Enderby, Engelter, Ferro, Gans, Godecke, Godecke, Godecke, Godecke, Godecke, Godecke, Godecke, Godecke, Goldberg, Gonzalez, Goodenough-Tregapnier, Goodenough-Trepagnier, Goodenough-Trepagnier, Goodglass, Goodglass, Greener, Greener, Gu, Gu, Hagelstein, Hagen, Harnish, Hartman, Hilari, Hinckley, Hinckley, Hoffmann, Holland, Holland, Howard, Howard, Huber, Ji, Jong-Hagelstein, Jong-Hagelstein, Jungblut, Kagan, Kalra, Kaplan, Katz, Katz, Katz, Katz, Katz, Katz, Kay, Kelly, Kendall, Kertesz, Kinsey, Kurt, Kurtzke, Kurtzke, Kurtzke, Lancker, Lara, Lara, Laska, Laska, Laska, Latimer, Lauterbach, Leal, Lee, Lendrem, Li, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Lincoln, Liu, Liu, Loeher, Lomas, Long, Long, Luo, Lyon, Mackay, Maher, Marcotte, Marshall, Marshall, Marshall, Marshall, Martins, Mattioli, Mattioli, McCall, Meikle, Meinzer, Meinzer, Meinzer, Meulen, Meulen, Meulen, Meulen, Moher, Moss, Nettleton, Nicholas, Nicholas, Nobis-Bosch, Nobis-Bosch, Nobis-Bosch, Nobis-Bosch, Oldfield, Osborne, Palmer, Palmer, Palmer, Palmer, Palmer, Palmer, Parr, Patchick, Pistarini, Popovici, Porch, Porch, Porch, Prins, Prins, Pulvermuller, Qiu, Quinteros, Rasmussen, Raven, Raymer, Raymer, Reinvang, Reinvang, Robey, Robey, Rochon, Rodrigues, Rodriguez, Rose, Rose, Rudd, Salonen, Sandt-Koenderman, Sarno, Schegloff, Schegloff, Schlaug, Schlaug, Schmah, Schuell, Schwartz, Shewan, Shewan, Shewan, Shewan, Shewan, Shewan, Shewan, Shewan, Sickert, Smania, Smania, Smith, Smith, Smith, Snodgrass, Soares, Sparks, Spreen, Stachowiak, Stachowiak, Stachowiak, Steenbrugge, Stoicheff, Stutcliffe, Swinburn, Szaflarski, Taylor, Thompson, Thompson, Thorndike, Thorsén, Toro, Tseng, Varley, Varley, Vauth, Vermeulen, Vines, Visch-Brink, Visch-Brink, Visch-Brink, Wang, Weiduschat, Wenke, Wenke, Wertz, Wertz, Wertz, Wertz, Wertz, West, West, Whiteside, Whiteside, Whitworth, Widén Holmqvist, Williams, Wilssens, Wolfe, Wood-Dauphinee, Woolf, Woolf, Woolf, Woolf, Wu, Wu, Xie, Xu, Yao, Yao, Yao, Yao, Young, Zhang, Zhang, Zhang, Zhang, Zhao, Zuckerman   +306 more
core   +3 more sources

Optimal statin use for prevention of sepsis in type 2 diabetes mellitus

Diabetology & Metabolic Syndrome, 2023
Purpose To investigate the dose-dependent protective effects of statins, specific classes of statins, and different intensities of statin use on sepsis risk in patients with type 2 diabetes mellitus (T2DM).
Mingyang Sun, Yuan Tao, Wan-Ming Chen, Szu-Yuan Wu, Jiaqiang Zhang   +4 more
doaj   +1 more source

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy

Haematologica, 2021
Chemotherapy dosages are often compromised, but most reports lack data on dosages that are actually delivered. In two consecutive acute lymphoblastic leukemia trials that differed in their asparaginase formulation, native E.
Seth E. Karol, Deqing Pei, Colton A. Smith, Yiwei Liu, Wenjian Yang, Nancy M. Kornegay, John C. Panetta, Kristine R. Crews, Cheng Cheng, Emily R. Finch, Hiroto Inaba, Monika L. Metzger, Jeffrey E. Rubnitz, Raul C. Ribeiro, Tanja A. Gruber, Jun J. Yang, William E. Evans, Sima Jeha, Ching-Hon Pui, Mary V. Relling   +19 more
doaj   +1 more source

Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study [PDF]

The Korean Journal of Internal Medicine
Background/Aims Optimal risk stratification based on simplified geriatric assessment to predict treatment-related toxicity and survival needs to be clarified in older patients with diffuse large B-cell lymphoma (DLBCL).
Ho-Young Yhim, Yong Park, Jeong-A Kim, Ho-Jin Shin, Young Rok Do, Joon Ho Moon, Min Kyoung Kim, Won Sik Lee, Dae Sik Kim, Myung-Won Lee, Yoon Seok Choi, Seong Hyun Jeong, Kyoung Ha Kim, Jinhang Kim, Chang-Hoon Lee, Ga-Young Song, Deok-Hwan Yang, Jae-Yong Kwak   +17 more
doaj   +1 more source